Literature DB >> 6234239

Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis.

C Gattringer, H Huber, T Radaszkiewicz, W Pfaller, H Braunsteiner.   

Abstract

The number and distribution of reactive T cells within 100 malignant B-cell lymphomas were evaluated in situ by immunomorphometry using stereological methods. Findings were related to histological and clinical parameters. A mean of 2 X 10(4) reactive T cells/microliter tumour tissue was found. This corresponds to 40% of the T-cell content of normal lymphatic tissues. The distribution of reactive T cells within the tumours was diffuse except for centroblastic/centrocytic lymphomas. When evaluating the different histological entities a correlation between number of helper T cells, T helper:T suppressor (TH:TS) ratio and histological subgroups emerged, particularly in non-Hodgkin lymphomas of low-grade malignancy. The highest ratio was found in prognostically favourable subgroups, CLL (2.7 +/- 0.3) and tumour areas of centroblastic/centrocytic lymphomas (2.9 +/- 0.4). In contrast, a significantly lower ratio was found in centrocytic lymphomas (1.4 +/- 0.3) corresponding well to the worst prognosis of this subgroup. The relationship between the number of helper T cells in tumour tissues, TH:TS ratio and prognosis was confirmed and extended by the evaluation of clinical data. It could be shown that, independently of histological criteria, a close correlation exists between the number of T cells, particularly T helper cells within the tumour, TH:TS ratio and clinical course. Patients with a favourable course had 1.4 X 10(4) T helper cells/microliter tumour tissue compared to only 0.8 X 10(4) for patients with an unfavourable clinical course (p less than 0.01); the TH:TS ratio was 2.8 for the favourable and 1.8 for the unfavourable group, respectively (p less than 0.04). In contrast, neither treatment nor tumour stage had a clear-cut influence on the extent of T-cell infiltration.

Entities:  

Mesh:

Year:  1984        PMID: 6234239     DOI: 10.1002/ijc.2910330607

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Immunophenotypic and genotypic characterization of diffuse mixed non-Hodgkin's lymphomas.

Authors:  W E Katzin; M D Linden; A J Fishleder; R R Tubbs
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

2.  Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.

Authors:  R Stauder; R Greil; T F Schulz; J Thaler; C Gattringer; T Radaskiewicz; M P Dierich; H Huber
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypes.

Authors:  G Gattringer; R Greil; T Radaszkiewicz; H Huber
Journal:  Blut       Date:  1986-07

4.  An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes.

Authors:  K Böheim; H Denz; C Böheim; H Glassl; H Huber
Journal:  Arch Otorhinolaryngol       Date:  1987

5.  Immunopathology of non-Hodgkin lymphomas.

Authors:  H Huber; C Gattringer; W Knapp; H Stein
Journal:  Klin Wochenschr       Date:  1984-11-02

6.  Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.

Authors:  R Greil; C Gattringer; T Schulz; W Knapp; T Radaskiewicz; M P Dierich; H Huber
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.